Literature DB >> 16418801

Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of TH2-type CD4+T lymphocytes and association with myocardial HLA-DR expression.

Friedhelm Kuethe1, Ruedi K Braun, Martin Foerster, Yvonne Schlenker, Holger H Sigusch, Claus Kroegel, Hans R Figulla.   

Abstract

BACKGROUND: An immunological pathogenesis underlying dilated cardiomyopathy and myocarditis has been suggested on the basis of the subtype of lymphocyte infiltrates and the degree of HLA expression in cardiac tissue. In the present study, we investigated the relation between the peripheral CD4+T-cell subset and the degree of HLA expression in the heart.
METHODS: Fifty-four patients with heart insufficiency included in the study were biopsied after coronary heart disease had been excluded. Immunohistological staining of the left ventricular tissue were performed employing anti-CD3, -CD4, -CD8, -CD14, and HLA-DR monoclonal antibodies. Intracellular expression of IL-2, IL-4, IL-5, IFN-gamma, and TNF-alpha in peripheral CD4+T lymphocytes was determined using flow cytometry. The severity of heart insufficiency was determined by measurement of brain natriuretic peptide (BNP) and the NYHA class. On the basis of HLA expression in the heart, the patients were divided into three groups: Group I (mild-to-none), Group II (moderate), and Group III (strong-to-very strong).
RESULTS: Of the 54 patients included in this study, 33 (61%) patients were diagnosed as having idiopathic dilated cardiomyopathy and 10 (18.5%) borderline or healing myocarditis according to the Dallas criteria. Both patient groups were found in all three HLA-DR groups. There was no difference in BNP level or NYHA class between the three groups. However, a significant difference in the proportion of CD4+T lymphocytes producing IL-2 (39.2 versus 21.8%), IFN-gamma (19.5 versus 7.8%), and TNF-alpha (35.8 versus 16.1%) between Groups I and III could be detected, whereas the distribution of IL-4 and IL-5 producing CD4+T lymphocytes was similar. The myocardium of Group III patients exhibited a significant higher number of CD3+T cells (11.4 versus 4.3 per mm2) and CD4+T cells (4.7 versus 0.8 per mm2) compared to Group I patients, while no difference existed with respect to CD8+T cells.
CONCLUSION: High myocardial expression of the HLA-DR antigen is associated with an increase of peripheral-blood CD4+T lymphocytes expressing cytokines of the TH2 subset. The degree of HLA-DR expression is not associated with the degree of heart insufficiency or underlying diagnosis, but correlates with an increase of activated T cells in the myocardium. The data suggest that CD4+T lymphocytes infiltrating cardiac tissue may play a pathogenic role in dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418801     DOI: 10.1007/s10875-006-7585-x

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  20 in total

Review 1.  Cytokines that regulate autoimmune responses.

Authors:  M Falcone; N Sarvetnick
Journal:  Curr Opin Immunol       Date:  1999-12       Impact factor: 7.486

2.  Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype.

Authors:  M Afanasyeva; Y Wang; Z Kaya; S Park; M J Zilliox; B H Schofield; S L Hill; N R Rose
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Myocarditis. A histopathologic definition and classification.

Authors:  H T Aretz; M E Billingham; W D Edwards; S M Factor; J T Fallon; J J Fenoglio; E G Olsen; F J Schoen
Journal:  Am J Cardiovasc Pathol       Date:  1987-01

4.  Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis.

Authors:  A Herskowitz; A Ahmed-Ansari; D A Neumann; W E Beschorner; N R Rose; L M Soule; C L Burek; K W Sell; K L Baughman
Journal:  J Am Coll Cardiol       Date:  1990-03-01       Impact factor: 24.094

5.  Phenotypic patterns of mononuclear cells in dilated cardiomyopathy.

Authors:  C Holzinger; A Schöllhammer; M Imhof; C Reinwald; G Kramer; A Zuckermann; E Wolner; G Steiner
Journal:  Circulation       Date:  1995-11-15       Impact factor: 29.690

6.  Serum-soluble CD4 as clinical and immunological marker in patients with dilated cardiomyopathy.

Authors:  G Klappacher; M Mehrabi; K Plesch; G Mundigler; M Pec; G Kramer; R Pacher; R Ullrich; W Kukutschki; M Imhof
Journal:  Immunol Lett       Date:  1993-10       Impact factor: 3.685

Review 7.  Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

Authors:  R S Liblau; S M Singer; H O McDevitt
Journal:  Immunol Today       Date:  1995-01

Review 8.  From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.

Authors:  C Kawai
Journal:  Circulation       Date:  1999-03-02       Impact factor: 29.690

Review 9.  Cellular and molecular mechanisms of murine autoimmune myocarditis.

Authors:  J M Penninger; C Pummerer; P Liu; N Neu; K Bachmaier
Journal:  APMIS       Date:  1997-01       Impact factor: 3.205

10.  Immunohistological diagnosis of myocarditis. Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury.

Authors:  R Wojnicz; E Nowalany-Kozielska; J Wodniecki; K Szczurek-Katański; J Nozyński; M Zembala; M M Rozek
Journal:  Eur Heart J       Date:  1998-10       Impact factor: 29.983

View more
  5 in total

1.  Angiotensin II-induced dilated cardiomyopathy in Balb/c but not C57BL/6J mice.

Authors:  Hongmei Peng; Xiao-Ping Yang; Oscar A Carretero; Pablo Nakagawa; Martin D'Ambrosio; Pablo Leung; Jiang Xu; Edward L Peterson; Germán E González; Pamela Harding; Nour-Eddine Rhaleb
Journal:  Exp Physiol       Date:  2011-05-20       Impact factor: 2.969

2.  Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy.

Authors:  Daniel Bulut; Michael Scheeler; Tim Wichmann; Jan Börgel; Thomas Miebach; Andreas Mügge
Journal:  Clin Res Cardiol       Date:  2010-04-25       Impact factor: 5.460

3.  Increases in circulating T lymphocytes expressing HLA-DR and CD40 ligand in patients with dilated cardiomyopathy.

Authors:  Atsuko Ueno; Kagari Murasaki; Nobuhisa Hagiwara; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

4.  TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.

Authors:  Eric D Abston; Michael J Coronado; Adriana Bucek; Jennifer A Onyimba; Jessica E Brandt; J Augusto Frisancho; Eunyong Kim; Djahida Bedja; Yoon-kyu Sung; Andrea J Radtke; Kathleen L Gabrielson; Wayne Mitzner; DeLisa Fairweather
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-12-19       Impact factor: 3.619

Review 5.  Role of cytokines and inflammation in heart function during health and disease.

Authors:  Monika Bartekova; Jana Radosinska; Marek Jelemensky; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.